Drug search by name

Trospium Extended-Release Capsules and Gastrointestinal obstruction

Result of checking the interaction of drug Trospium Extended-Release Capsules and disease Gastrointestinal obstruction for safety when used together.

Check result:

Trospium Extended-Release Capsules <> Gastrointestinal obstruction

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Trospium antagonizes the effect of acetylcholine on muscarinic receptors. Its parasympatholytic action reduces the tonus of smooth muscle. Trospium, like other antimuscarinic agents, may decrease gastrointestinal motility and should be used with caution in patients with conditions such as ulcerative colitis, intestinal atony and myasthenia gravis. Caution should be exercised when using trospium in patients with gastrointestinal obstructive disorders because of the risk of gastric retention.

Trospium Extended-Release Capsules

Generic Name: trospium

Brand Name: Sanctura, Sanctura XR, Regurin

Synonyms: Trospium

What is Trospium Extended-Release Capsules?